Trinity Biotech Total Liabilities 2010-2024 | TRIB
Trinity Biotech total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Trinity Biotech Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $83 |
| 2022 | $94 |
| 2021 | $119 |
| 2020 | $133 |
| 2019 | $126 |
| 2018 | $108 |
| 2017 | $128 |
| 2016 | $141 |
| 2015 | $150 |
| 2014 | $46 |
| 2013 | $43 |
| 2012 | $28 |
| 2011 | $20 |
| 2010 | $20 |
| 2009 | $53 |
| Trinity Biotech Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $124 |
| 2024-06-30 | $124 |
| 2024-03-31 | $113 |
| 2023-12-31 | $83 |
| 2023-09-30 | $81 |
| 2023-06-30 | $83 |
| 2023-03-31 | $98 |
| 2022-12-31 | $94 |
| 2022-09-30 | $91 |
| 2022-06-30 | $91 |
| 2022-03-31 | $112 |
| 2021-12-31 | $119 |
| 2021-09-30 | $122 |
| 2021-06-30 | $125 |
| 2021-03-31 | $136 |
| 2020-12-31 | $133 |
| 2020-09-30 | $129 |
| 2020-06-30 | $129 |
| 2020-03-31 | $128 |
| 2019-12-31 | $126 |
| 2019-09-30 | $134 |
| 2019-06-30 | $133 |
| 2019-03-31 | $128 |
| 2018-12-31 | $108 |
| 2018-09-30 | $115 |
| 2018-06-30 | $128 |
| 2018-03-31 | $129 |
| 2017-12-31 | $128 |
| 2017-09-30 | $138 |
| 2017-06-30 | $138 |
| 2017-03-31 | $136 |
| 2016-12-31 | $141 |
| 2016-09-30 | $150 |
| 2016-06-30 | $147 |
| 2016-03-31 | $148 |
| 2015-12-31 | $150 |
| 2015-09-30 | $144 |
| 2015-06-30 | $155 |
| 2015-03-31 | $46 |
| 2014-12-31 | $46 |
| 2014-09-30 | $42 |
| 2014-06-30 | $42 |
| 2014-03-31 | $40 |
| 2013-12-31 | $43 |
| 2013-09-30 | $48 |
| 2013-06-30 | $29 |
| 2013-03-31 | $29 |
| 2012-12-31 | $28 |
| 2012-09-30 | $25 |
| 2012-06-30 | $24 |
| 2012-03-31 | $23 |
| 2011-12-31 | $20 |
| 2011-09-30 | $21 |
| 2011-06-30 | $21 |
| 2011-03-31 | $21 |
| 2010-12-31 | $20 |
| 2010-09-30 | $21 |
| 2010-06-30 | $21 |
| 2010-03-31 | $50 |
| 2009-12-31 | $53 |
| 2009-09-30 | $54 |
| 2009-06-30 | $59 |
| 2009-03-31 | $57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.006B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| ICU Medical (ICUI) | United States | $3.751B | 35.71 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.605B | 30.05 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Zynex (ZYXI) | United States | $0.268B | 56.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |